Literature DB >> 2983349

Characterization of a protein, released by the T47D cell line, immunologically related to the major envelope protein of mouse mammary tumor virus.

N Segev, A Hizi, F Kirenberg, I Keydar.   

Abstract

The T47D human mammary adenocarcinoma cell line in vitro releases viral particles as well as soluble proteins. Both fractions were shown to contain antigens that immunologically crossreact with the major glycoprotein (gp52) of mouse mammary tumor virus. The crossreacting antigens are located on polypeptides with apparent molecular weights of about 68,000 and 60,000. The larger one is present in viral particles whereas both are found in the soluble fraction. Both proteins are glycosylated. The human tissue culture proteins differ from gp52 not only in molecular weight but also in charge heterogenity and in polypeptide profiles obtained after partial proteolysis. The results suggest that there is a restricted similarity between MMTV gp52 and the immunologically related T47D proteins.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2983349      PMCID: PMC397297          DOI: 10.1073/pnas.82.5.1531

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  17 in total

1.  THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY.

Authors:  F C GREENWOOD; W M HUNTER; J S GLOVER
Journal:  Biochem J       Date:  1963-10       Impact factor: 3.857

2.  Establishment and characterization of a cell line of human breast carcinoma origin.

Authors:  I Keydar; L Chen; S Karby; F R Weiss; J Delarea; M Radu; S Chaitcik; H J Brenner
Journal:  Eur J Cancer       Date:  1979-05       Impact factor: 9.162

3.  High resolution two-dimensional electrophoresis of proteins.

Authors:  P H O'Farrell
Journal:  J Biol Chem       Date:  1975-05-25       Impact factor: 5.157

4.  Detection of viral proteins in mouse mammary tumors by immunoperoxidase staining of paraffin sections.

Authors:  I Keydar; R Mesa-Tejada; M Ramanarayanan; T Ohno; C Fenoglio; R Hu; S Spiegelman
Journal:  Proc Natl Acad Sci U S A       Date:  1978-03       Impact factor: 11.205

5.  The purification of a gs antigen of the murine mammary tumor virus and its quantitation by radioimmunoassay.

Authors:  E Ritzi; A Baldi; S Spiegelman
Journal:  Virology       Date:  1976-11       Impact factor: 3.616

6.  Studies on the amino acid sequence content of proteins specified by the gag and pol genes of avian sarcoma virus B77.

Authors:  A Hizi; M A McCrae; W K Joklik
Journal:  Virology       Date:  1978-08       Impact factor: 3.616

Review 7.  Mammary tumor viruses.

Authors:  D H Moore; C A Long; A B Vaidya; J B Sheffield; A S Dion; E Y Lasfargues
Journal:  Adv Cancer Res       Date:  1979       Impact factor: 6.242

8.  Immunohistochemical detection of a cross-reacting virus antigen in mouse mammary tumors and human breast carcinomas.

Authors:  R Mesa-Tejada; I Keydar; M Ramanarayanan; T Ohno; C Fenoglio; S Spiegelman
Journal:  J Histochem Cytochem       Date:  1978-07       Impact factor: 2.479

9.  Presence of a mouse mammary tumor virus-related antigen in human breast carcinoma cells and its absence from normal mammary epithelial cells.

Authors:  N S Yang; C M McGrath; P Furmanski
Journal:  J Natl Cancer Inst       Date:  1978-11       Impact factor: 13.506

10.  Human breast carcinoma antigen is immunologically related to the polypeptide of the group-specific glycoprotein of mouse mammary tumor virus.

Authors:  T Ohno; R Mesa-Tejada; I Keydar; M Ramanarayanan; J Bausch; S Spiegelman
Journal:  Proc Natl Acad Sci U S A       Date:  1979-05       Impact factor: 11.205

View more
  10 in total

1.  Breast Cancer: A Revolutionary Concept.

Authors: 
Journal:  Breast Cancer       Date:  1995-04-30       Impact factor: 4.239

2.  Production and characterization of monoclonal antibodies identifying breast tumor-associated antigens.

Authors:  I Keydar; C S Chou; M Hareuveni; I Tsarfaty; E Sahar; G Selzer; S Chaitchik; A Hizi
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

3.  Transcription and in vitro translation of the dsRNA virus isolated from Rhizoctonia solani.

Authors:  A Finkler; B S Ben-Zvi; Y Koltin; I Barash
Journal:  Virus Genes       Date:  1988-03       Impact factor: 2.332

4.  Stimulation of expression of the human endogenous retrovirus genome by female steroid hormones in human breast cancer cell line T47D.

Authors:  M Ono; M Kawakami; H Ushikubo
Journal:  J Virol       Date:  1987-06       Impact factor: 5.103

5.  Nucleotide sequence of human endogenous retrovirus genome related to the mouse mammary tumor virus genome.

Authors:  M Ono; T Yasunaga; T Miyata; H Ushikubo
Journal:  J Virol       Date:  1986-11       Impact factor: 5.103

Review 6.  Human endogenous retroviruses: nature, occurrence, and clinical implications in human disease.

Authors:  H B Urnovitz; W H Murphy
Journal:  Clin Microbiol Rev       Date:  1996-01       Impact factor: 26.132

7.  Human endogenous retrovirus (HERV-K) reverse transcriptase as a breast cancer prognostic marker.

Authors:  Maya Golan; Amnon Hizi; James H Resau; Neora Yaal-Hahoshen; Hadar Reichman; Iafa Keydar; Ilan Tsarfaty
Journal:  Neoplasia       Date:  2008-06       Impact factor: 5.715

8.  Expression of human sequences related to those of mouse mammary tumor virus.

Authors:  G C Franklin; S Chretien; I M Hanson; H Rochefort; F E May; B R Westley
Journal:  J Virol       Date:  1988-04       Impact factor: 5.103

9.  Cell surface-associated anti-MUC1-derived signal peptide antibodies: implications for cancer diagnostics and therapy.

Authors:  Riva Kovjazin; Galit Horn; Nechama I Smorodinsky; Michael Y Shapira; Lior Carmon
Journal:  PLoS One       Date:  2014-01-08       Impact factor: 3.240

10.  Collective radioresistance of T47D breast carcinoma cells is mediated by a Syncytin-1 homologous protein.

Authors:  Roberto Chignola; Michela Sega; Barbara Molesini; Anna Baruzzi; Sabrina Stella; Edoardo Milotti
Journal:  PLoS One       Date:  2019-01-30       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.